Trader consensus reflects a 72% implied probability for the CDC issuing a Level 3 Travel Health Notice—"Avoid Nonessential Travel"—by December 31, driven by persistent H5N1 avian influenza risks, with 71 confirmed U.S. human cases since February 2024 (two deaths, mostly mild among exposed workers) amid widespread animal outbreaks in dairy cows and poultry. No person-to-person transmission detected, per latest FluView (week ending April 18, 2026, no new cases). Compounding factors include clade II mpox outbreaks in Ghana and Liberia (current Level 2 notice since January 2026) and U.S. measles surges surpassing 1,700 cases (22 new outbreaks, 93% outbreak-associated), threatening elimination status. No Level 3 notices active; weekly surveillance updates will clarify escalation potential.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$113,862 Vol.
$113,862 Vol.
$113,862 Vol.
$113,862 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Market Opened: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus reflects a 72% implied probability for the CDC issuing a Level 3 Travel Health Notice—"Avoid Nonessential Travel"—by December 31, driven by persistent H5N1 avian influenza risks, with 71 confirmed U.S. human cases since February 2024 (two deaths, mostly mild among exposed workers) amid widespread animal outbreaks in dairy cows and poultry. No person-to-person transmission detected, per latest FluView (week ending April 18, 2026, no new cases). Compounding factors include clade II mpox outbreaks in Ghana and Liberia (current Level 2 notice since January 2026) and U.S. measles surges surpassing 1,700 cases (22 new outbreaks, 93% outbreak-associated), threatening elimination status. No Level 3 notices active; weekly surveillance updates will clarify escalation potential.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions